We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Graft Polymer (uk) Plc | LSE:GPL | London | Ordinary Share | GB00BMD1Z199 | ORD GBP0.001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.005 | -3.13% | 0.155 | 0.15 | 0.16 | 0.17 | 0.145 | 0.16 | 9,942,295 | 13:13:58 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Services, Nec | 542k | -2.71M | -0.0260 | -0.06 | 156.15k |
TIDMGPL
RNS Number : 9916Y
Graft Polymer (UK) PLC
08 January 2024
8 January 2024
PDMR Share Dealing
Graft Polymer (UK) Plc ("Company") announces that on 4 January 2024, ordinary shares of GBP0.001 each in the Company ("Ordinary Shares") were disposed of by a person discharging managerial responsibility ("PDMR") in the Company as listed below.
Name Role Nature of Number of Ordinary Shares transaction Chief Executive Transfer of Victor Bolduev Officer, Director Ordinary Shares 10,750,000 -------------------- ------------------ --------------------------
It is further announced that on 4 January 2024, Ordinary Shares were subscribed for (subject to various conditions being met, including approval by the FCA, and publication, of a prospectus ("Conditions")) ("Subscription") by certain PDMRs and persons closely associated with PDMRs as listed below.
Name Role Nature of Number of Ordinary Shares transaction Conditional subscription Chief Executive for Ordinary Victor Bolduev Officer, Director Shares 22,529,166 (1) -------------------- --------------- -------------------------- Conditional subscription for Ordinary Roby Zomer Chairman, Director Shares 11,111,000 -------------------- --------------- -------------------------- Conditional subscription Chief Financial for Ordinary Yifat Steuer Officer, Director Shares 11,711,167 -------------------- --------------- -------------------------- Conditional subscription Chief Marketing for Ordinary Pavel Kobzev Officer, Director Shares 8,694,000 (2) -------------------- --------------- -------------------------- Conditional subscription for Ordinary Alexander Brooks Director Shares 2,810,667 -------------------- --------------- -------------------------- Conditional subscription for Ordinary Anthony Eastman Company Secretary Shares 2,810,667 (3) -------------------- --------------- --------------------------
(1) Of which 11,760,333 Ordinary Shares were subscribed for by Polymer Innovations Inc., a company controlled by Victor Bolduev.
(2) Of which 5,675,167 Ordinary Shares were subscribed for by MSW Ltd, a company controlled by Pavel Kobzev.
(3) These Ordinary Shares were subscribed for by Tournesol Consulting Ltd, a company controlled by Anthony Eastman.
A further announcement is expected to be made upon the Conditions having been met.
About Graft Polymer
Graft Polymer is a London Stock Exchange listed company (GPL.L) with a cutting-edge, research and development (R&D) and manufacturing facility based in Slovenia which has already introduced more than 50 products to the market. The core business of the Group comprises polymer modification and drug delivery system developments. The Group has developed a proprietary set of polymer modification technologies which uses recycled raw materials and a closed loop system to reduce waste. Graft Polymer's technology can improve existing products and processing methodologies by enhancing performance, simplifying manufacturing, reducing material consumption, widening the choice of feedstocks, and reducing costs.
Graft Polymer has three divisions: polymer modification; IP for Bio/Pharma applications including a drug delivery system (Graft Bio) and the Group's food supplement division. A significant milestone was reached in May 2022 when the Slovenian manufacturing facility was granted a Hazard Analysis and Critical Control Point (HACCP) Certificate. The HACCP Certificate allows it to enter the lucrative Business-to-Consumer market and commercialise its IP for bio/pharma applications, developing active pharmaceutical ingredients and drug delivery platforms for use in the food supplement market, thereby introducing a further revenue stream to its business.
Environment, Social and Governance is at the forefront of the Group's strategy and the facility in Slovenia has been granted ISO 14001 accreditation in recognition of the environmental management systems in place to reduce waste. Graft Polymer only uses REACH and ROHS certificated raw materials instead of toxic raw materials, and its extensive R&D programme has also developed specialised recycling polymer additives which increases the strength of recycled blends and plastic products whilst also reducing plastic waste by between 40 and 50 per cent.
For further information, visit www.graftpolymer.com , follow on Twitter @PolymerLtd or contact:
Graft Polymer (UK) Plc
Roby Zomer, Non-Executive Chairman info@graftpolymer.com
Yifat Steuer, CFO and Executive Director
Notification of dealings in shares by PDMRs of the Company:
1. Details of PDMR / PDMR Associate === ==================================================================== (a) Name Victor Bolduev === ======================= =========================================== (b) Position / status Chief Executive Officer, Director === ======================= =========================================== (c) Initial notification Initial notification / amendment === ======================= =========================================== 2. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted === ==================================================================== (d) Description of Ordinary Shares in Graft Polymer (UK) Plc the financial instrument === ======================= =========================================== (e) Nature of the Disposal of Ordinary Shares transaction === ======================= =========================================== (f) Price(s) and Price per Ordinary Share: 0.6 pence volume(s) Volume: 10,750,000 === ======================= =========================================== (g) Aggregated information n/a Aggregated volume Price === ======================= =========================================== (h) Date of the transaction 4 January 2024 === ======================= =========================================== (i) Place of the London, United Kingdom transaction === ======================= =========================================== 1. Details of PDMR / PDMR Associate === ========================================================================== (a) Name Victor Bolduev === ======================= ================================================= (b) Position / status Chief Executive Officer, Director === ======================= ================================================= (c) Initial notification Initial notification / amendment === ======================= ================================================= 2. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted === ========================================================================== (d) Description of Ordinary Shares in Graft Polymer (UK) Plc the financial instrument === ======================= ================================================= (e) Nature of the Subscription of Ordinary Shares (subject to the transaction Conditions, as defined above, being met) === ======================= ================================================= (f) Price(s) and Price per Ordinary Share: 0.6 pence volume(s) Volume: 10,768,833 === ======================= ================================================= (g) Aggregated information n/a Aggregated volume Price === ======================= ================================================= (h) Date of the transaction 4 January 2024 === ======================= ================================================= (i) Place of the London, United Kingdom transaction === ======================= ================================================= 1. Details of PDMR / PDMR Associate === ======================================================================= (a) Name Polymer Innovations Inc. === ======================= ============================================== (b) Position / status Company controlled by Victor Bolduev === ======================= ============================================== (c) Initial notification Initial notification / amendment
=== ======================= ============================================== 2. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted === ======================================================================= (d) Description of Ordinary Shares in Graft Polymer (UK) Plc the financial instrument === ======================= ============================================== (e) Nature of the Conditional subscription for Ordinary Shares transaction === ======================= ============================================== (f) Price(s) and Price per Ordinary Share: 0.6 pence volume(s) Volume: 11,760,333 === ======================= ============================================== (g) Aggregated information n/a Aggregated volume Price === ======================= ============================================== (h) Date of the transaction 4 January 2024 === ======================= ============================================== (i) Place of the London, United Kingdom transaction === ======================= ============================================== 1. Details of PDMR / PDMR Associate === ======================================================================= (a) Name Roby Zomer === ======================= ============================================== (b) Position / status Chairman, Director === ======================= ============================================== (c) Initial notification Initial notification / amendment === ======================= ============================================== 2. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted === ======================================================================= (d) Description of Ordinary Shares in Graft Polymer (UK) Plc the financial instrument === ======================= ============================================== (e) Nature of the Conditional subscription for Ordinary Shares transaction === ======================= ============================================== (f) Price(s) and Price per Ordinary Share: 0.6 pence volume(s) Volume: 11,111,000 === ======================= ============================================== (g) Aggregated information n/a Aggregated volume Price === ======================= ============================================== (h) Date of the transaction 4 January 2024 === ======================= ============================================== (i) Place of the London, United Kingdom transaction === ======================= ============================================== 1. Details of PDMR / PDMR Associate === ======================================================================= (a) Name Yifat Steuer === ======================= ============================================== (b) Position / status Chief Financial Officer, Director === ======================= ============================================== (c) Initial notification Initial notification / amendment === ======================= ============================================== 2. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted === ======================================================================= (d) Description of Ordinary Shares in Graft Polymer (UK) Plc the financial instrument === ======================= ============================================== (e) Nature of the Conditional subscription for Ordinary Shares transaction === ======================= ============================================== (f) Price(s) and Price per Ordinary Share: 0.6 pence volume(s) Volume: 11,711,167 === ======================= ============================================== (g) Aggregated information n/a Aggregated volume Price === ======================= ============================================== (h) Date of the transaction 4 January 2024 === ======================= ============================================== (i) Place of the London, United Kingdom transaction === ======================= ============================================== 1. Details of PDMR / PDMR Associate === ======================================================================= (a) Name Pavel Kobzev === ======================= ============================================== (b) Position / status Chief Marketing Officer, Director === ======================= ============================================== (c) Initial notification Initial notification / amendment === ======================= ============================================== 2. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted === ======================================================================= (d) Description of Ordinary Shares in Graft Polymer (UK) Plc the financial instrument === ======================= ============================================== (e) Nature of the Conditional subscription for Ordinary Shares transaction === ======================= ============================================== (f) Price(s) and Price per Ordinary Share: 0.6 pence volume(s) Volume: 3,018,833 === ======================= ============================================== (g) Aggregated information n/a Aggregated volume Price === ======================= ============================================== (h) Date of the transaction 4 January 2024 === ======================= ============================================== (i) Place of the London, United Kingdom transaction === ======================= ============================================== 1. Details of PDMR / PDMR Associate === ======================================================================= (a) Name MSW Ltd === ======================= ============================================== (b) Position / status Company controlled by Pavel Kobzev === ======================= ============================================== (c) Initial notification Initial notification / amendment === ======================= ============================================== 2. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted === ======================================================================= (d) Description of Ordinary Shares in Graft Polymer (UK) Plc the financial instrument === ======================= ============================================== (e) Nature of the Conditional subscription for Ordinary Shares transaction === ======================= ============================================== (f) Price(s) and Price per Ordinary Share: 0.6 pence volume(s) Volume: 5,675,167 === ======================= ============================================== (g) Aggregated information n/a Aggregated volume Price === ======================= ============================================== (h) Date of the transaction 4 January 2024 === ======================= ============================================== (i) Place of the London, United Kingdom transaction === ======================= ============================================== 1. Details of PDMR / PDMR Associate === ======================================================================= (a) Name Alexander Brooks === ======================= ============================================== (b) Position / status Director === ======================= ============================================== (c) Initial notification Initial notification / amendment === ======================= ============================================== 2. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted === ======================================================================= (d) Description of Ordinary Shares in Graft Polymer (UK) Plc the financial instrument === ======================= ============================================== (e) Nature of the Conditional subscription for Ordinary Shares transaction === ======================= ============================================== (f) Price(s) and Price per Ordinary Share: 0.6 pence volume(s) Volume: 2,810,667 === ======================= ==============================================
(g) Aggregated information n/a Aggregated volume Price === ======================= ============================================== (h) Date of the transaction 4 January 2024 === ======================= ============================================== (i) Place of the London, United Kingdom transaction === ======================= ============================================== 1. Details of PDMR / PDMR Associate === ======================================================================= (a) Name Tournesol Consulting Ltd === ======================= ============================================== (b) Position / status Company controlled by Anthony Eastman === ======================= ============================================== (c) Initial notification Initial notification / amendment === ======================= ============================================== 2. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted === ======================================================================= (d) Description of Ordinary Shares in Graft Polymer (UK) Plc the financial instrument === ======================= ============================================== (e) Nature of the Conditional subscription for Ordinary Shares transaction === ======================= ============================================== (f) Price(s) and Price per Ordinary Share: 0.6 pence volume(s) Volume: 2,810,667 === ======================= ============================================== (g) Aggregated information n/a Aggregated volume Price === ======================= ============================================== (h) Date of the transaction 4 January 2024 === ======================= ============================================== (i) Place of the London, United Kingdom transaction === ======================= ==============================================
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFLFFSLSITIIS
(END) Dow Jones Newswires
January 08, 2024 12:00 ET (17:00 GMT)
1 Year Graft Polymer (uk) Chart |
1 Month Graft Polymer (uk) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions